GlassScriptPhysician profile
Leah Elk
NPI 1629366992
$2,312.14
in general payments reported to CMS, 2019-2025
21 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $467 · 2022: $491 · 2023: $642 · 2024: $479 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.54 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $522.18 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $441.15 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $223.25 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $169.88 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.93 | 2021-2024 | |
| Coopersurgical, INC. | $112.72 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Optumhealth Care Solutions, LLC | $104.20 | 2023-2025 | Vivify Health Care Team Portal, Eitan Medical, Vivify Health Care Team Portal 001 |
| Medline Industries LP | $96.88 | 2022 | |
| Organon LLC | $92.20 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $91.27 | 2021-2022 | |
| Exeltis, USA INC. | $73.90 | 2021-2025 | Slynd |
| Merck Sharp & Dohme LLC | $38.11 | 2021 | |
| Myovant Sciences INC. | $36.55 | 2022 | |
| Millicent US INC | $32.67 | 2023-2025 | Femlyv, Femring, Intrarosa |
| Avion Pharmaceuticals | $28.92 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $26.82 | 2024 | |
| Becton, Dickinson and Company | $25.05 | 2024 | Bd Max System, Bd Max Instrument |
| Daiichi Sankyo INC. | $19.80 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.76 | 2021 | |
| Novo Nordisk INC | $18.34 | 2024 | Wegovy |
| Pfizer INC. | $15.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Elk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.